Updates in Molecular Profiling of Pancreatic Ductal Adenocarcinoma
Jaewon James Lee MD, Jen Jen Yeh MD
Despite significant research efforts and clinical trials, pancreatic ductal adenocarcinoma (PDAC) remains a deadly disease and is now projected to become the second leading cause of cancer-related deaths by 2030.1